Marshall Wace’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-82,373
| Closed | -$2.46M | – | 3456 |
|
|
2025
Q3 | $2.46M | Buy |
82,373
+48,105
| +140% | +$1.61M | ﹤0.01% | 1515 |
|
|
2025
Q2 | $1.02M | Sell |
34,268
-80,843
| -70% | -$2.33M | ﹤0.01% | 1839 |
|
|
2025
Q1 | $3.51M | Buy |
115,111
+86,976
| +309% | +$2.93M | ﹤0.01% | 1213 |
|
|
2024
Q4 | $1.11M | Buy |
28,135
+19,635
| +231% | +$764K | ﹤0.01% | 1684 |
|
|
2024
Q3 | $330K | Buy |
+8,500
| New | +$344K | ﹤0.01% | 2094 |
|
|
2024
Q2 | – | Sell |
-43,981
| Closed | -$1.29M | – | 2936 |
|
|
2024
Q1 | $1.29M | Sell |
43,981
-8,573
| -16% | -$273K | ﹤0.01% | 1545 |
|
|
2023
Q4 | $1.91M | Sell |
52,554
-9,190
| -15% | -$301K | ﹤0.01% | 1239 |
|
|
2023
Q3 | $1.98M | Buy |
61,744
+539
| +0.9% | +$18.3K | ﹤0.01% | 1226 |
|
|
2023
Q2 | $1.92M | Buy |
61,205
+18,441
| +43% | +$421K | ﹤0.01% | 1423 |
|
|
2023
Q1 | $974K | Buy |
+42,764
| New | +$1.1M | ﹤0.01% | 1829 |
|
|
2022
Q1 | – | Sell |
-1,725
| Closed | -$83K | – | 3977 |
|
|
2021
Q4 | $83K | Buy |
+1,725
| New | +$86.9K | ﹤0.01% | 3429 |
|
|
2021
Q1 | – | Sell |
-27,202
| Closed | -$1.18M | – | 2831 |
|
|
2020
Q4 | $1.18M | Sell |
27,202
-8,741
| -24% | -$344K | 0.01% | 1147 |
|
|
2020
Q3 | $1.4M | Buy |
35,943
+10,385
| +41% | +$456K | 0.01% | 905 |
|
|
2020
Q2 | $1.1M | Sell |
25,558
-27,352
| -52% | -$1.04M | 0.01% | 968 |
|
|
2020
Q1 | $1.76M | Sell |
52,910
-24,909
| -32% | -$899K | 0.02% | 668 |
|
|
2019
Q4 | $3.22M | Sell |
77,819
-21,505
| -22% | -$905K | 0.02% | 672 |
|
|
2019
Q3 | $4.54M | Sell |
99,324
-32,826
| -25% | -$1.43M | 0.04% | 534 |
|
|
2019
Q2 | $5.71M | Buy |
132,150
+79,908
| +153% | +$3.37M | 0.05% | 435 |
|
|
2019
Q1 | $2.27M | Sell |
52,242
-5,473
| -9% | -$279K | 0.02% | 703 |
|
|
2018
Q4 | $2.73M | Buy |
+57,715
| New | +$3.46M | 0.03% | 649 |
|
Other funds holding SRDX
Marshall Wace's SRDX Position: Q4 2025 in Review
Marshall Wace sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 82,373 shares — an estimated $2.46M sold.
Marshall Wace first reported a position in SRDX in Q4 2018 and held it in 20 quarters. The position peaked at $5.71M in Q2 2019. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.
- Marshall Wace reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
- Marshall Wace sold 82,373 Surmodics shares in Q4 2025, an estimated $2.46M.
- Marshall Wace first reported a position in Surmodics in Q4 2018 and held it in 20 quarters.
- Marshall Wace's Surmodics position peaked at $5.71M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.